FDA Shared Exclusivity Decision May Stem From FTC Influence – Attny Fleder
Executive Summary
FDA's decision to award "shared" exclusivity for generic Prilosec may be a signal of a subtle effect of the Federal Trade Commission on the agency, Hyman, Phelps & McNamara attorney John Fleder suggested